Recent Developments in Building Robust Health System Partnerships for Life Sciences (2025)

Transaction activity between health systems and life sciences firms is set to increase in 2025, with 70% of life sciences executives expecting higher deal volume, particularly in biotechnology, and in areas like artificial intelligence and cybersecurity1.

Strategic partnerships are being driven by industry needs such as labor challenges in healthcare providers, ongoing shifts to value-based care, and portfolio updates in life sciences ahead of key patent expirations1.

Multiple partnership models are emerging, allowing organizations to select the best-fit structure for collaboration based on their specific needs4.

Digital transformation is central to these partnerships, with platforms like Salesforce's Life Sciences Cloud enabling pharma and medical technology organizations to integrate real-time data and AI-driven tools to improve research, clinical operations, and commercial activities5.

The 2025 outlook points to a trend where certified partner networks and ecosystems, including industry-specific software and consulting services, play a critical role in accelerating technology adoption and enhancing collaboration across the health system and life sciences landscape5.

Sources:

1. https://www.thinkbrg.com/news/strategic-partnerships-and-private-equity-to-fuel-increased-healthcare-and-life-sciences-transaction-activity-in-2025-new-brg-report-finds/

4. https://www.advisory.com/topics/partnership/ls-health-system-partnership-models

5. https://www.salesforce.com/news/press-releases/2025/05/08/partner-network-for-life-sciences-announcement/